Company Cellid, Co., Ltd.

Equities

A299660

KR7299660001

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Bio Therapeutic Drugs

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-06-25 pm EDT			5-day change	1st Jan Change
2,040 ^KRW	-5.99%		-19.21%	-54.36%

2023	Cellid, Co., Ltd.(KOSDAQ:A299660) dropped from S&P Global BMI Index	CI
2021	Private S.Korea firms plan $5.4 billion investment to create vaccine hub	RE

Cellid, Co., Ltd. is a Korea-based company mainly engaged in the research and development of cancer therapeutic vaccine. The Company develops cancer therapeutic vaccine through development and clinical research of BVAC pipeline products using CeliVax original technology.

Managers	Title	Age	Since
Chang-Yul Kang CEO	Chief Executive Officer	70	-
Min-Soo Kim DFI	Director of Finance/CFO	50	-
BeomSoo Han BRD	Director/Board Member	-	-
Yookyung Kim BRD	Director/Board Member	-	-
Myung-Hwan Park AUD	Comptroller/Controller/Auditor	68	-

Members of the board	Title	Age	Since
Chang-Yul Kang CEO	Chief Executive Officer	70	-
Yookyung Kim BRD	Director/Board Member	-	-
BeomSoo Han BRD	Director/Board Member	-	-
Wie Jong Kwak BRD	Director/Board Member	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	13,602,977	10,749,166 ( 79.02 %)	0	79.02 %

Name	Equities	%	Valuation
Chang-Yul Kang 15.02 %	2,042,642	15.02 %	4 M ₩
Su-won Kang 0.8197 %	111,500	0.8197 %	229 515 ₩
Mi-ja Kang 0.7792 %	106,000	0.7792 %	218 194 ₩
Dong-min Kang 0.7351 %	100,000	0.7351 %	205 843 ₩
Bok-ja Kang 0.7315 %	99,500	0.7315 %	204 814 ₩
Jung-Wha Lee 0.5470 %	74,407	0.5470 %	153 162 ₩
Chang-ik Kang 0.5293 %	72,000	0.5293 %	148 207 ₩
Jong-chul Kim 0.2996 %	40,752	0.2996 %	83 885 ₩
Kyung-sook Jang 0.2342 %	31,856	0.2342 %	65 573 ₩
Tae-woo Kim 0.1985 %	27,000	0.1985 %	55 578 ₩

Cellid Co., Ltd.

Seoul Uni Bldg.142 Suite 504 1 Gwanak-ro

08826, Seoul

http://www.cellid.co.kr

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
CELLID, CO., LTD.	-54.36%	21.22M
VERTEX PHARMACEUTICALS INCORPORATED	+16.49%	122B
REGENERON PHARMACEUTICALS, INC.	+21.73%	116B
ARGENX SE	+22.18%	27.03B
BIONTECH SE	-21.81%	20.36B
GENMAB A/S	-16.89%	16.43B
BEIGENE, LTD.	-18.81%	15.91B
WUXI APPTEC CO., LTD.	-44.74%	15.6B
SAREPTA THERAPEUTICS, INC.	+62.72%	14.94B
NEUROCRINE BIOSCIENCES, INC.	+3.09%	13.59B

Bio Therapeutic Drugs